Serological immune response against ADAM10 pro-domain is associated with favourable prognosis in stage III colorectal cancer patients

Sheila María Álvarez-Fernández, Marco Barbariga, Luca Cannizzaro, Carlo Vittorio Cannistraci, Laura Hurley, Alan Zanardi, Antonio Conti, Francesca Sanvito, Anna Innocenzi, Nicolò Pecorelli, Marco Braga, Massimo Alessio

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Serological immune response against ADAM10 pro-domain is associated with favourable prognosis in stage III colorectal cancer patients'. Together they form a unique fingerprint.

Immunology and Microbiology